1月12day,"Shenzhen Medical Associationinterventional medicinebranch2023年academicannual meeting andChina Liver Cancer Interventional MDT Alliance《TACEguidelines(2023edition)》interpretationlecture tour"afterShenzhenheld,The conference was hosted by the Shenzhen Medical Association and organized by Shenzhen People's Hospital and the Interventional Medicine Branch. It aimed to promote the vigorous development of interventional medicine through academic exchange and dialogue with outstanding figures in the field!
Professor Dou Yongchong, Honorary Chairman of the Interventional Medicine Branch and Discipline Leader of the Oncology Center at Shenzhen Huaqiao Hospital, served as Honorary Chairman of the conference. Director Chen Xudong, Chairman of the Interventional Medicine Branch, served as Conference Chairman. Distinguished guests included Academician Teng Gaojun of the Chinese Academy of Sciences, Professor Dong Wenguang, Standing Committee Member of the Tumor Hyperthermia Committee of the China Anti-Cancer Association and Director of the Oncology Center at Shenzhen Huaqiao Hospital, and other renowned national experts fullydiscussedlatest developments in their respective fieldsresearchachievementscentering on"minimally invasive interventional tumor treatment"以sub-venuein the form ofin-depth的discussed和exchanged。
Professor Dou Yongchong stated in an interview: ""No longer relying on traditional open surgery, with just a thin catheter or puncture needle, we can precisely reach tumors inside the body. A few-millimeter ablation needle, inserted into the tumor, can inactivate it. This latest minimally invasive tumor treatment approach effectively complements traditional treatment methods. Thistechnologywhat ordinary people often call 'treating with a single needle'"tumor"。It provides patients with safer, more effective, and minimally invasive treatment options. In the future, with continuous technological innovation and improvement, minimally invasive interventional treatment will continue to play an important role in medicine, bringing patients better treatment experiences and quality of life."。
Professor Dou Yongchongdelivering concluding remarks
《TACEguidelines(2023)Third Edition Grand Release, Chinese Academy of SciencesAcademician、ChinaMedical Doctor AssociationinterventionalPresident of the Physicians Branch, Zhongda Hospital affiliated with Southeast UniversityhospitalPresidentTeng Gaojunintroducedsaid,"TACEguidelinesis a disciplinetechnologya sign of maturity,TACEguidelinesadopting the most rigorousmethoddevelopment process, where each piece of evidence, literature screening, and the final draft all went throughinterventionalin the discipline fieldexpertProfessorthe most detailed discussions, developed based on the best available medical evidence,Meanwhilealso based on ourChina的doctor，especiallyinterventionaldisciplinedoctor的practiceas the foundation, verysuitable， and internationalinterventionaldisciplineexpertA total ofknowledge is also highly consistent and very meaningful; this is a truly raretechnology. EspeciallyTACEcombinedsystemic treatmentnow receivingwidelyapplication"。
Teng GaojunProfessorspeechinterpretationTACEguidelines(2023edition)
minimally invasive interventional tumorcombinedsystemic treatment为tumor patientsbringingMoretreatmentoptionmarkingtumortreatment is moving towards a moreprecision、individualizeddirectiondevelopment。aftercontinuously的research和innovationwe expect to seeMore的tumor patientsThereforebenefit,China Anti-Cancer Associationtumor hyperthermiaCommittee Standing Member, Shenzhen Huaqiao Hospital Oncology CenterdirectorProfessor Dong Wenguanginterview中stated:" minimally invasive interventional tumor是aftermedicalimaging equipmenthighprecisionguidance,delivering anti-cancer drugs totumorcorethe lesionespecially applying itcombinedtumorgreenhyperthermiatreating various advanced-stagemalignanttumorcan achieve"高precisionhigh-dose, highefficacy、low damage"的characteristics，maximummaximizing protection of normal tissue function, allowingpatientsafterpainlessnon-invasiveduring treatmentcancer，maximumdegreeimprovelong-termefficacy，Meanwhileguaranteepatients的quality of lifeextending advanced-stagepatientssurvival period. Itssignificantly的clinicalTreatment Outcomesreceiving more and morepatientsrecognition and trust."。
Professor Dong Wenguangstated in an interview
this sessionconferencedistinguished experts gathered on a grand scale, with wisdom surging,lasting2days ofconferenceheld multiple high-endacademicreport，exchangedsharedminimally invasive interventionacademicachievementsdiscussing cutting-edgeacademicand disseminating cutting-edgetechnology. Fortumorworkers,especiallyfrom事interventional medicinemedical workers provided an opportunity for mutual learning,exchanged的platformpromotingChinainterventional medicinehigh-qualitydevelopmentcontributing wisdom and and strength!